{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "antioxidant", "inflammation", "medicinal plants", "phytotherapy"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34833873", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "03"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "10"}], "Language": ["eng"], "ELocationID": ["6783", "10.3390/molecules26226783"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "22", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "10"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions.", "Abstract": {"AbstractText": ["The novel coronavirus disease (COVID-19), the reason for worldwide pandemic, has already masked around 220 countries globally. This disease is induced by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Arising environmental stress, increase in the oxidative stress level, weak immunity and lack of nutrition deteriorates the clinical status of the infected patients. Though several researches are at its peak for understanding and bringing forward effective therapeutics, yet there is no promising solution treating this disease directly. Medicinal plants and their active metabolites have always been promising in treating many clinical complications since time immemorial. Mother nature provides vivid chemical structures, which act multi-dimensionally all alone or synergistically in mitigating several diseases. Their unique antioxidant and anti-inflammatory activity with least side effects have made them more effective candidate for pharmacological studies. These medicinal plants inhibit attachment, encapsulation and replication of COVID-19 viruses by targeting various signaling molecules such as angiotensin converting enzyme-2, transmembrane serine protease 2, spike glycoprotein, main protease etc. This property is re-examined and its potency is now used to improve the existing global health crisis. This review is an attempt to focus various antiviral activities of various noteworthy medicinal plants. Moreover, its implications as prophylactic or preventive in various secondary complications including neurological, cardiovascular, acute kidney disease, liver disease are also pinpointed in the present review. This knowledge will help emphasis on the therapeutic developments for this novel coronavirus where it can be used as alone or in combination with the repositioned drugs to combat COVID-19."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology & Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, WB, India."}], "LastName": "Saha", "ForeName": "Priyanka", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology & Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, WB, India."}], "LastName": "Bose", "ForeName": "Subhankar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology & Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, WB, India."}], "LastName": "Srivastava", "ForeName": "Amit Kumar", "Initials": "AK"}, {"Identifier": ["0000-0002-1506-7836"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSUI), Riyadh 11623, Saudi Arabia."}], "LastName": "Chaudhary", "ForeName": "Anis Ahmad", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Noble Pharma, LLC, 4602 Domain Drive, Menomonie, WI 54751, USA."}], "LastName": "Lall", "ForeName": "Rajiv", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Noble Pharma, LLC, 4602 Domain Drive, Menomonie, WI 54751, USA."}], "LastName": "Prasad", "ForeName": "Sahdeo", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "ACE2 protein, human"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["complications", "pathology", "virology"], "DescriptorName": "COVID-19"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Cardiovascular Diseases"}, {"QualifierName": [], "DescriptorName": "Drug Repositioning"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["isolation & purification", "physiology"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Spike Glycoprotein, Coronavirus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Internalization"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ghosh B., Biswas A. Status evaluation of provinces affected by COVID-19: A qualitative assessment using fuzzy system. Appl. Soft Comput. 2021;109:107540. doi: 10.1016/j.asoc.2021.107540.", "ArticleIdList": ["10.1016/j.asoc.2021.107540", "PMC8169225", "34093096"]}, {"Citation": "Lee C.C., Ali K., Connell D., Mordi I.R., George J., Lang E.M., Lang C.C. COVID-19-Associated Cardiovascular Complications. Diseases. 2021;9:47. doi: 10.3390/diseases9030047.", "ArticleIdList": ["10.3390/diseases9030047", "PMC8293160", "34209705"]}, {"Citation": "Zacharias H., Dubey S., Koduri G., D\u2019Cruz D. Rheumatological complications of Covid 19. Autoimmun. Rev. 2021;20:102883. doi: 10.1016/j.autrev.2021.102883.", "ArticleIdList": ["10.1016/j.autrev.2021.102883", "PMC8256657", "34237419"]}, {"Citation": "Qian J.-Y., Wang B., Liu B.-C. Acute kidney injury in the 2019 novel coronavirus disease. Kidney Dis. 2020;6:318\u2013323. doi: 10.1159/000509086.", "ArticleIdList": ["10.1159/000509086", "PMC7360511", "32742978"]}, {"Citation": "Darenskaya M., Kolesnikova L., Kolesnikov S. The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic. Curr. Pharm. Des. 2021;27:1618\u20131627. doi: 10.2174/1381612827666210222113351.", "ArticleIdList": ["10.2174/1381612827666210222113351", "33618639"]}, {"Citation": "Mehri F., Rahbar A.H., Ghane E.T., Souri B., Esfahani M. The comparison of oxidative markers between Covid-19 patients and healthy subjects: Oxidative stress and Covid-19. Arch. Med. Res. 2021 doi: 10.1016/j.arcmed.2021.06.004.", "ArticleIdList": ["10.1016/j.arcmed.2021.06.004", "PMC8180845", "34154831"]}, {"Citation": "Esper F.P., Cheng Y.-W., Adhikari T.M., Tu Z.J., Li D., Li E.A., Farkas D.H., Procop G.W., Ko J.S., Chan T.A. Genomic epidemiology of SARS-CoV-2 infection during the initial pandemic wave and association with disease severity. JAMA Netw. Open. 2021;4:e217746. doi: 10.1001/jamanetworkopen.2021.7746.", "ArticleIdList": ["10.1001/jamanetworkopen.2021.7746", "PMC8076962", "33900399"]}, {"Citation": "Saha P., Banerjee A.K., Tripathi P.P., Srivastava A.K., Ray U. A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity. Biosci. Rep. 2020;40:BSR20201312. doi: 10.1042/BSR20201312.", "ArticleIdList": ["10.1042/BSR20201312", "PMC7225408", "32378705"]}, {"Citation": "Garcia-Beltran W.F., Lam E.C., Astudillo M.G., Yang D., Miller T.E., Feldman J., Hauser B.M., Caradonna T.M., Clayton K.L., Nitido A.D. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021;184:476\u2013488.e11. doi: 10.1016/j.cell.2020.12.015.", "ArticleIdList": ["10.1016/j.cell.2020.12.015", "PMC7837114", "33412089"]}, {"Citation": "Ntyonga-Pono M.-P. COVID-19 infection and oxidative stress: An under-explored approach for prevention and treatment? Pan Afr. Med. J. 2020;35((Suppl. 2)):12. doi: 10.11604/pamj.supp.2020.35.2.22877.", "ArticleIdList": ["10.11604/pamj.supp.2020.35.2.22877", "PMC7266475", "32528623"]}, {"Citation": "Biswas S.K. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid. Med. Cell. Longev. 2016;2016:5698931. doi: 10.1155/2016/5698931.", "ArticleIdList": ["10.1155/2016/5698931", "PMC4736408", "26881031"]}, {"Citation": "Hussain T., Tan B., Yin Y., Blachier F., Tossou M.C., Rahu N. Oxidative stress and inflammation: What polyphenols can do for us? Oxid. Med Cell. Longev. 2016;2016:7432797. doi: 10.1155/2016/7432797.", "ArticleIdList": ["10.1155/2016/7432797", "PMC5055983", "27738491"]}, {"Citation": "Iddir M., Brito A., Dingeo G., Fernandez Del Campo S.S., Samouda H., La Frano M.R., Bohn T. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: Considerations during the COVID-19 crisis. Nutrients. 2020;12:1562. doi: 10.3390/nu12061562.", "ArticleIdList": ["10.3390/nu12061562", "PMC7352291", "32471251"]}, {"Citation": "Shakya A.K. Medicinal plants: Future source of new drugs. Int. J. Herb. Med. 2016;4:59\u201364."}, {"Citation": "Sen B. Potentiality and possibility of Medicinal Plants on Ayurvedic Principle in prevention and treatment of COVID-19. J. Ayu. Herb. Med. 2020;6:100\u2013107. doi: 10.31254/jahm.2020.6216.", "ArticleIdList": ["10.31254/jahm.2020.6216"]}, {"Citation": "Zhang L., Ravipati A.S., Koyyalamudi S.R., Jeong S.C., Reddy N., Smith P.T., Bartlett J., Shanmugam K., M\u00fcnch G., Wu M. Antioxidant and anti-inflammatory activities of selected medicinal plants containing phenolic and flavonoid compounds. J. Agric. Food Chem. 2011;59:12361\u201312367. doi: 10.1021/jf203146e.", "ArticleIdList": ["10.1021/jf203146e", "22023309"]}, {"Citation": "Saha P., Choudhury P.R., Das S., Talukdar A.D., Choudhury M.D. In vitro antioxidant activity of bark extracts of Oroxylum indicum (L.) vent. Asian J. Pharm. Clin. Res. 2017;10:263\u2013266. doi: 10.22159/ajpcr.2017.v10i8.18977.", "ArticleIdList": ["10.22159/ajpcr.2017.v10i8.18977"]}, {"Citation": "Atawodi S. Antioxidant potential of African medicinal plants. Afr. J. Biotechnol. 2005;4:128\u2013133."}, {"Citation": "Murugesan D., Deviponnuswamy R. Potential anti-inflammatory medicinal plants-a review. Int. J. Pharm. Pharm. Sci. 2014;6:43\u201349."}, {"Citation": "Siriwatanametanon N., Fiebich B.L., Efferth T., Prieto J.M., Heinrich M. Traditionally used Thai medicinal plants: In vitro anti-inflammatory, anticancer and antioxidant activities. J. Ethnopharmacol. 2010;130:196\u2013207. doi: 10.1016/j.jep.2010.04.036.", "ArticleIdList": ["10.1016/j.jep.2010.04.036", "20435130"]}, {"Citation": "Galloway S.E., Paul P., MacCannell D.R., Johansson M.A., Brooks J.T., MacNeil A., Slayton R.B., Tong S., Silk B.J., Armstrong G.L., et al. Emergence of SARS-CoV-2 b. 1.1. 7 lineage\u2014United States, December 29, 2020\u2013January 12, 2021. Morb. Mortal. Wkly. Rep. 2021;70:95\u201399. doi: 10.15585/mmwr.mm7003e2.", "ArticleIdList": ["10.15585/mmwr.mm7003e2", "PMC7821772", "33476315"]}, {"Citation": "Hamming I., Timens W., Bulthuis M., Lely A., Navis G.V., van Goor H. Ireland, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631\u2013637. doi: 10.1002/path.1570.", "ArticleIdList": ["10.1002/path.1570", "PMC7167720", "15141377"]}, {"Citation": "Bourgonje A.R., Abdulle A.E., Timens W., Hillebrands J.L., Navis G.J., Gordijn S.J., Bolling M.C., Dijkstra G., Voors A.A., Osterhaus A.D. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19) J. Pathol. 2020;251:228\u2013248. doi: 10.1002/path.5471.", "ArticleIdList": ["10.1002/path.5471", "PMC7276767", "32418199"]}, {"Citation": "Rahman N., Basharat Z., Yousuf M., Castaldo G., Rastrelli L., Khan H. Virtual screening of natural products against type II transmembrane serine protease (TMPRSS2), the priming agent of coronavirus 2 (SARS-CoV-2) Molecules. 2020;25:2271. doi: 10.3390/molecules25102271.", "ArticleIdList": ["10.3390/molecules25102271", "PMC7287752", "32408547"]}, {"Citation": "Karcioglu O., Afacan G., Ozkaya B., Yilmaz E., Ersan E., Yeniocak S., Hosseinzadeh M. Cytokine storm, corticosteroids and interleukin-6 receptor antibodies in context of antiinflammatory treatment in COVID-19. J. Pharm. Res. Int. 2020;32:67\u201375. doi: 10.9734/jpri/2020/v32i2530824.", "ArticleIdList": ["10.9734/jpri/2020/v32i2530824"]}, {"Citation": "Ma H., Zeng W., He H., Zhao D., Jiang D., Zhou P., Cheng L., Li Y., Ma X., Jin T. Serum IgA, IgM, and IgG responses in COVID-19. Cell. Mol. Immunol. 2020;17:773\u2013775. doi: 10.1038/s41423-020-0474-z.", "ArticleIdList": ["10.1038/s41423-020-0474-z", "PMC7331804", "32467617"]}, {"Citation": "Remy K.E., Mazer M., Striker D.A., Ellebedy A.H., Walton A.H., Unsinger J., Blood T.M., Mudd P.A., Yi D.J., Mannion D.A. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020;5:e140329. doi: 10.1172/jci.insight.140329.", "ArticleIdList": ["10.1172/jci.insight.140329", "PMC7526441", "32687484"]}, {"Citation": "Soy M., Keser G., Atag\u00fcnd\u00fcz P., Tabak F., Atag\u00fcnd\u00fcz I., Kayhan S. Cytokine storm in COVID-19: Pathogenesis and overview of anti-inflammatory agents used in treatment. Clin. Rheumatol. 2020;39:2085\u20132094. doi: 10.1007/s10067-020-05190-5.", "ArticleIdList": ["10.1007/s10067-020-05190-5", "PMC7260446", "32474885"]}, {"Citation": "Vaninov N. In the eye of the COVID-19 cytokine storm. Nat. Rev. Immunol. 2020;20:277. doi: 10.1038/s41577-020-0305-6.", "ArticleIdList": ["10.1038/s41577-020-0305-6", "PMC7132547", "32249847"]}, {"Citation": "Sun Z., He G., Huang N., Thilakavathy K., Lim J.C.W., Kumar S.S., Xiong C. Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19. Front. Pharmacol. 2021;12:1740.", "ArticleIdList": ["PMC8298820", "34305613"]}, {"Citation": "Rocha M.N.D., Alves D.R., Marinho M.M., Morais S.M.d., Marinho E.S. Virtual screening of citrus flavonoid tangeretin: A promising pharmacological tool for the treatment and prevention of Zika fever and COVID-19. J. Comput. Biophys. Chem. 2021;20:283\u2013304. doi: 10.1142/S2737416521500137.", "ArticleIdList": ["10.1142/S2737416521500137"]}, {"Citation": "Adem S., Eyupoglu V., Sarfraz I., Rasul A., Ali M. Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: An in silico strategy unveils a hope against CORONA. Preprints. 2020:2020030333. doi: 10.20944/preprints202003.0333.v1.", "ArticleIdList": ["10.20944/preprints202003.0333.v1", "PMC8957318", "35364308"]}, {"Citation": "Tallei T.E., Tumilaar S.G., Niode N.J., Kepel B.J., Idroes R., Effendi Y., Sakib S.A., Emran T.B. Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: A molecular docking study. Scientifica. 2020;2020:6307457. doi: 10.1155/2020/6307457.", "ArticleIdList": ["10.1155/2020/6307457", "PMC7773461", "33425427"]}, {"Citation": "Omar S., Bouziane I., Bouslama Z., Djemel A. In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin converting enzyme 2 (ACE2) from natural products: Quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxy-chloroquine against COVID-19 main protease active site and ACE2. ChemRxiv. 2020 doi: 10.26434/chemrxiv.12181404.v1. Version 1.", "ArticleIdList": ["10.26434/chemrxiv.12181404.v1"]}, {"Citation": "Murck H. Symptomatic protective action of glycyrrhizin (licorice) in COVID-19 infection? Front. Immunol. 2020;11:1239. doi: 10.3389/fimmu.2020.01239.", "ArticleIdList": ["10.3389/fimmu.2020.01239", "PMC7270278", "32574273"]}, {"Citation": "Dabaghian F., Khanavi M., Zarshenas M.M. Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19. Med. Hypotheses. 2020;143:109841. doi: 10.1016/j.mehy.2020.109841.", "ArticleIdList": ["10.1016/j.mehy.2020.109841", "PMC7229719", "32425303"]}, {"Citation": "Jin Y.-H., Min J.S., Jeon S., Lee J., Kim S., Park T., Park D., Jang M.S., Park C.M., Song J. Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections. Phytomed. 2021;86:153440. doi: 10.1016/j.phymed.2020.153440.", "ArticleIdList": ["10.1016/j.phymed.2020.153440", "PMC7738280", "33376043"]}, {"Citation": "Ohashi H., Watashi K., Saso W., Shionoya K., Iwanami S., Hirokawa T., Shirai T., Kanaya S., Ito Y., Kim K.S. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience. 2021;24:102367. doi: 10.1016/j.isci.2021.102367.", "ArticleIdList": ["10.1016/j.isci.2021.102367", "PMC7997640", "33817567"]}, {"Citation": "Gani M.A., Nurhan A.D., Maulana S., Siswodihardjo S., Shinta D.W., Khotib J. Structure-based virtual screening of bioactive compounds from Indonesian medical plants against severe acute respiratory syndrome coronavirus-2. J. Adv. Pharm. Technol. Res. 2021;12:120\u2013126.", "ArticleIdList": ["PMC8177144", "34159141"]}, {"Citation": "Shakya A., Chikhale R.V., Bhat H.R., Alasmary F.A., Almutairi T.M., Ghosh S.K., Alhajri H.M., Alissa S.A., Nagar S., Islam M.A. Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors. Mol. Divers. 2021:1\u201314. doi: 10.1007/s11030-021-10209-3.", "ArticleIdList": ["10.1007/s11030-021-10209-3", "PMC8009078", "33786727"]}, {"Citation": "Sawikowska A. Meta-analysis of flavonoids with antiviral potential against coronavirus. Biom. Lett. 2020;57:13\u201322. doi: 10.2478/bile-2020-0002.", "ArticleIdList": ["10.2478/bile-2020-0002"]}, {"Citation": "Liu H., Ye F., Sun Q., Liang H., Li C., Li S., Lu R., Huang B., Tan W., Lai L. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. J. Enzym. Inhib. Med. Chem. 2021;36:497\u2013503. doi: 10.1080/14756366.2021.1873977.", "ArticleIdList": ["10.1080/14756366.2021.1873977", "PMC7850424", "33491508"]}, {"Citation": "Remali J., Aizat W.M. A review on plant bioactive compounds and their modes of action against coronavirus infection. Front. Pharmacol. 2020;11:589044. doi: 10.3389/fphar.2020.589044.", "ArticleIdList": ["10.3389/fphar.2020.589044", "PMC7845143", "33519449"]}, {"Citation": "Khan A., Heng W., Wang Y., Qiu J., Wei X., Peng S., Saleem S., Khan M., Ali S.S., Wei D.Q. In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro) Phytother. Res. 2021;35:2841\u20132845. doi: 10.1002/ptr.6998.", "ArticleIdList": ["10.1002/ptr.6998", "PMC8013176", "33448101"]}, {"Citation": "Alagu Lakshmi S., Shafreen R.M.B., Priya A., Shunmugiah K.P. Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: Using structure-based drug discovery approach. J. Biomol. Struct. Dyn. 2020;39:4594\u20134609. doi: 10.1080/07391102.2020.1778537.", "ArticleIdList": ["10.1080/07391102.2020.1778537", "PMC7332876", "32573351"]}, {"Citation": "Chidambaram S.K., Ali D., Alarifi S., Radhakrishnan S., Akbar I. In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2. J. Biomol. Struct. Dyn. 2020;13:1671\u20131677.", "ArticleIdList": ["PMC7505582", "33008777"]}, {"Citation": "Abd El-Aziz N.M., Shehata M.G., Eldin Awad O.M., El-Sohaimy S.A. Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: Molecular docking analysis. Egypt. J. Chem. 2021;64:1989\u20132001."}, {"Citation": "He C.-L., Huang L.-Y., Wang K., Gu C.-J., Hu J., Zhang G.-J., Xu W., Xie Y.-H., Tang N., Huang A.-L. Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products. Signal. Transduct. Target. Ther. 2021;6:1\u20133. doi: 10.1038/s41392-021-00531-5.", "ArticleIdList": ["10.1038/s41392-021-00531-5", "PMC7985570", "33758167"]}, {"Citation": "Jo S., Kim S., Kim D.Y., Kim M.-S., Shin D.H. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J. Enzym. Inhib. Med. Chem. 2020;35:1539\u20131544. doi: 10.1080/14756366.2020.1801672.", "ArticleIdList": ["10.1080/14756366.2020.1801672", "PMC7470085", "32746637"]}, {"Citation": "Muralikumar V., Ramakrishnamacharya C., Seshachalam C. Technology, Inhibitory effect of phytochemicals from Azadirachta indica a juss. and Tinospora cordifolia (thunb.) miers against SARS-COV-2 mpro and spike protease\u2014An in silico analysis. Int. J. Eng. Appl. Sci. 2020;5:303\u2013319."}, {"Citation": "Kumar V., Dhanjal J.K., Kaul S.C., Wadhwa R., Sundar D. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. J. Biomol. Struct. Dyn. 2020;39:3842\u20133854. doi: 10.1080/07391102.2020.1772108.", "ArticleIdList": ["10.1080/07391102.2020.1772108", "PMC7284143", "32431217"]}, {"Citation": "Srivastava A., Siddiqui S., Ahmad R., Mehrotra S., Ahmad B., Srivastava A. Exploring nature\u2019s bounty: Identification of Withania somnifera as a promising source of therapeutic agents against COVID-19 by virtual screening and in silico evaluation. J. Biomol. Struct. Dyn. 2020:1\u201351. doi: 10.1080/07391102.2020.1835725.", "ArticleIdList": ["10.1080/07391102.2020.1835725", "PMC7755033", "33246398"]}, {"Citation": "Javed H., Meeran M.F.N., Jha N.K., Ojha S. Carvacrol, a Plant Metabolite Targeting Viral Protease (Mpro) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19. Front. Plant. Sci. 2020;11:601335. doi: 10.3389/fpls.2020.601335.", "ArticleIdList": ["10.3389/fpls.2020.601335", "PMC7921315", "33664752"]}, {"Citation": "Gurung A.B., Ali M.A., Lee J., Farah M.A., Al-Anazi K.M. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach. Life Sci. 2020;255:117831. doi: 10.1016/j.lfs.2020.117831.", "ArticleIdList": ["10.1016/j.lfs.2020.117831", "PMC7243810", "32450166"]}, {"Citation": "Sabet R., Sisakht M., Emami L., Sabahi Z. Comparison of COVID-19 Virus Main Protease Inhibition Activities of Phenolic Acids By Molecular Docking. Trends Pharmacol. Sci. 2021;7:117\u2013126."}, {"Citation": "Kulkarni S.A., Nagarajan S.K., Ramesh V., Palaniyandi V., Selvam S.P., Madhavan T. Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein. J. Mol. Struct. 2020;1221:128823. doi: 10.1016/j.molstruc.2020.128823.", "ArticleIdList": ["10.1016/j.molstruc.2020.128823", "PMC7334662", "32834111"]}, {"Citation": "Jamali N., Soureshjani E.H., Mobini G.-R., Samare-Najaf M., Clark C.C., Saffari-Chaleshtori J. Medicinal plant compounds as promising inhibitors of coronavirus (COVID-19) main protease: An in silico study. J. Biomol. Struct. Dyn. 2021:1\u201312. doi: 10.1080/07391102.2021.1906749.", "ArticleIdList": ["10.1080/07391102.2021.1906749", "33970805"]}, {"Citation": "Al-Zahrani A.A. Rutin as a promising inhibitor of main protease and other protein targets of Covid-19: In silico study. J. Nat. Prod. Commun. 2020;15:1934578X20953951. doi: 10.1177/1934578X20953951.", "ArticleIdList": ["10.1177/1934578X20953951"]}, {"Citation": "Senthil Kumar K., Gokila Vani M., Wang C.-S., Chen C.-C., Chen Y.-C., Lu L.-P., Huang C.-H., Lai C.-S., Wang S.-Y. Geranium and lemon essential oils and their active compounds downregulate angiotensin-converting enzyme 2 (ACE2), a SARS-CoV-2 spike receptor-binding domain, in epithelial cells. Plants. 2020;9:770. doi: 10.3390/plants9060770.", "ArticleIdList": ["10.3390/plants9060770", "PMC7355681", "32575476"]}, {"Citation": "Ghosh R., Chakraborty A., Biswas A., Chowdhuri S. Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Torreya nucifera leaves. J. Biomol. Struct. Dyn. 2020:1\u201316. doi: 10.1080/07391102.2020.1841680.", "ArticleIdList": ["10.1080/07391102.2020.1841680", "PMC7663460", "33140695"]}, {"Citation": "Firdiana E.R., Renjana E., Ningrum L.W., Angio M.H., Nikmatullah M., Rizal S. In Silico Study of the Active Compounds of Lindera aggregata (Sims) Kosterm as Anti-coronavirus. Curr. Nutr. Food. Sci. 2021;17:408\u2013416. doi: 10.2174/1573401316999200901181217.", "ArticleIdList": ["10.2174/1573401316999200901181217"]}, {"Citation": "Chikhale R.V., Sinha S.K., Patil R.B., Prasad S.K., Shakya A., Gurav N., Prasad R., Dhaswadikar S.R., Wanjari M., Gurav S.S. In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19. J. Biomol. Struct. Dyn. 2020;39:5033\u20135047. doi: 10.1080/07391102.2020.1784289.", "ArticleIdList": ["10.1080/07391102.2020.1784289", "32579064"]}, {"Citation": "Cheng L., Zheng W., Li M., Huang J., Bao S., Xu Q., Ma Z. Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2.  [(accessed on 3 November 2021)];Preprints. 2020 :1\u20137. Available online:  https://www.preprints.org/manuscript/202002.0313/v1.", "ArticleIdList": ["PMC8844329", "35157175"]}, {"Citation": "Chen Q., Lan H.-Y., Peng W., Rahman K., Liu Q.-C., Luan X., Zhang H. Pharmacology, Isatis indigotica: A review of phytochemistry, pharmacological activities and clinical applications. J. Pharm. Pharmacol. 2021;73:1137\u20131150. doi: 10.1093/jpp/rgab014.", "ArticleIdList": ["10.1093/jpp/rgab014", "PMC8249990", "33779758"]}, {"Citation": "Daglia M., Di Lorenzo A., Nabavi S.F., Talas Z.S., Nabavi S.M. Polyphenols: Well beyond the antioxidant capacity: Gallic acid and related compounds as neuroprotective agents: You are what you eat! Curr. Pharm. Biotechnol. 2014;15:362\u2013372. doi: 10.2174/138920101504140825120737.", "ArticleIdList": ["10.2174/138920101504140825120737", "24938889"]}, {"Citation": "Lucas K., Fr\u00f6hlich-Nowoisky J., Oppitz N., Ackermann M. Cinnamon and hop extracts as potential immunomodulators for severe COVID-19 cases. Front. Plant. Sci. 2021;12:263. doi: 10.3389/fpls.2021.589783.", "ArticleIdList": ["10.3389/fpls.2021.589783", "PMC7952639", "33719281"]}, {"Citation": "Shi Y.-H., Huang Y.-F., Wang W.-Y., Yang L., Zhou H., Sang Z. Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment. Pharmacol. Res. 2020;160:105074. doi: 10.1016/j.phrs.2020.105074.", "ArticleIdList": ["10.1016/j.phrs.2020.105074", "PMC7347313", "32653649"]}, {"Citation": "Panyod S., Ho C.-T., Sheen L.-Y. Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective. J. Tradit. Complement. Med. Mol. Divers. 2020;10:420\u2013427. doi: 10.1016/j.jtcme.2020.05.004.", "ArticleIdList": ["10.1016/j.jtcme.2020.05.004", "PMC7260602", "32691006"]}, {"Citation": "Upreti S., Prusty J.S., Pandey S.C., Kumar A., Samant M. Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19) Mol. Divers. 2021;25:1795\u20131809. doi: 10.1007/s11030-020-10159-2.", "ArticleIdList": ["10.1007/s11030-020-10159-2", "PMC7781418", "33398633"]}, {"Citation": "Lau K.-M., Lee K.-M., Koon C.-M., Cheung C.S.-F., Lau C.-P., Ho H.-M., Lee M.Y.-H., Au S.W.-N., Cheng C.H.-K., Bik-San Lau C. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J. Ethnopharmacol. 2008;118:79\u201385. doi: 10.1016/j.jep.2008.03.018.", "ArticleIdList": ["10.1016/j.jep.2008.03.018", "PMC7126383", "18479853"]}, {"Citation": "Wen C.-C., Shyur L.-F., Jan J.-T., Liang P.-H., Kuo C.-J., Arulselvan P., Wu J.-B., Kuo S.-C., Yang N.-S.J. Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J. Tradit. Complement. Med. 2011;1:41\u201350. doi: 10.1016/S2225-4110(16)30055-4.", "ArticleIdList": ["10.1016/S2225-4110(16)30055-4", "PMC3942999", "24716104"]}, {"Citation": "Shawky E., Nada A.A., Ibrahim R.S. Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: Identifying related therapeutic targets using network pharmacology and molecular docking analyses. RSC Adv. 2020;10:27961\u201327983. doi: 10.1039/D0RA05126H.", "ArticleIdList": ["10.1039/D0RA05126H", "PMC9055652", "35519104"]}, {"Citation": "Pamukova-Michaelson R., Vodenicharova A., Mihaylov C. Effect of Combined Therapies on Respiratory Diseases and Covid-19. Gen. Med. 2020;22:59\u201366."}, {"Citation": "Khubber S., Hashemifesharaki R., Mohammadi M., Gharibzahedi S.M.T. Garlic (Allium sativum L.): A potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19. Nutr. J. 2020;19:1\u20133. doi: 10.1186/s12937-020-00643-8.", "ArticleIdList": ["10.1186/s12937-020-00643-8", "PMC7673072", "33208167"]}, {"Citation": "Zhang D., Zhang B., Lv J.-T., Sa R.-N., Zhang X.-M., Lin Z.-J. The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. Pharmacol. Res. 2020;157:104882. doi: 10.1016/j.phrs.2020.104882.", "ArticleIdList": ["10.1016/j.phrs.2020.104882", "PMC7198419", "32380051"]}, {"Citation": "Bag A., Bag A. Treatment of COVID-19 patients: Justicia adhatoda leaves extract is a strong remedy for COVID-19\u2013Case report analysis and docking based study. ChemRxiv. 2020:1\u20137. doi: 10.26434/chemrxiv.12038604.v1.", "ArticleIdList": ["10.26434/chemrxiv.12038604.v1"]}, {"Citation": "Sinha S.K., Prasad S.K., Islam M.A., Gurav S.S., Patil R.B., AlFaris N.A., Aldayel T.S., AlKehayez N.M., Wabaidur S.M., Shakya A. Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: A pharmacoinformatics study. J. Biomol. Struct. Dyn. 2021;39:4686\u20134700. doi: 10.1080/07391102.2020.1779132.", "ArticleIdList": ["10.1080/07391102.2020.1779132", "PMC7309308", "32552462"]}, {"Citation": "Adhikari B., Marasini B.P., Rayamajhee B., Bhattarai B.R., Lamichhane G., Khadayat K., Adhikari A., Khanal S., Parajuli N. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phytother. Res. 2021;35:1298\u20131312. doi: 10.1002/ptr.6893.", "ArticleIdList": ["10.1002/ptr.6893", "PMC7675695", "33037698"]}, {"Citation": "Subbaiyan A., Ravichandran K., Singh S.V., Sankar M., Thomas P., Dhama K., Malik Y.S., Singh R.K., Chaudhuri P. In silico molecular docking analysis targeting SARS-CoV-2 spike protein and selected herbal constituents. J. Pure Appl. Microbiol. 2020;14:989\u2013998. doi: 10.22207/JPAM.14.SPL1.37.", "ArticleIdList": ["10.22207/JPAM.14.SPL1.37"]}, {"Citation": "Seyran M., Takayama K., Uversky V.N., Lundstrom K., Pal\u00f9 G., Sherchan S.P., Attrish D., Rezaei N., Aljabali A.A., Ghosh S. The structural basis of accelerated host cell entry by SARS-CoV-2. FEBS Jr. 2020;288:5010\u20135020. doi: 10.1111/febs.15651.", "ArticleIdList": ["10.1111/febs.15651", "PMC7753708", "33264497"]}, {"Citation": "Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R.J.S. Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science. 2003;300:1763\u20131767. doi: 10.1126/science.1085658.", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Lung J., Lin Y.S., Yang Y.H., Chou Y.L., Shu L.H., Cheng Y.C., Liu H.T., Wu C.Y. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. J. Med. Virol. 2020;92:693\u2013697. doi: 10.1002/jmv.25761.", "ArticleIdList": ["10.1002/jmv.25761", "PMC7228302", "32167173"]}, {"Citation": "Nawrot-Hadzik I., Zmudzinski M., Matkowski A., Preissner R., K\u0119sik-Brodacka M., Hadzik J., Drag M., Abel R. Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors\u2013Molecular Docking and In Vitro Study. Pharmaceuticals. 2021;14:742. doi: 10.3390/ph14080742.", "ArticleIdList": ["10.3390/ph14080742", "PMC8399519", "34451839"]}, {"Citation": "Garg S., Anand A., Lamba Y., Roy A. Molecular docking analysis of selected phytochemicals against SARS-CoV-2 M pro receptor. Vegetos. 2020;33:766\u2013781. doi: 10.1007/s42535-020-00162-1.", "ArticleIdList": ["10.1007/s42535-020-00162-1", "PMC7567421", "33100613"]}, {"Citation": "Suru\u010di\u0107 R., Tubi\u0107 B., Stojiljkovi\u0107 M.P., Djuric D.M., Travar M., Grabe\u017e M., \u0160avikin K., \u0160krbi\u0107 R. Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization. Mol. Cell. Biochem. 2021;476:1179\u20131193. doi: 10.1007/s11010-020-03981-7.", "ArticleIdList": ["10.1007/s11010-020-03981-7", "PMC7668668", "33200379"]}, {"Citation": "Murugan N.A., Pandian C.J., Jeyakanthan J.S. Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials. J. Biomol. Struct. Dyn. 2021;39:4415\u20134426. doi: 10.1080/07391102.2020.1777901.", "ArticleIdList": ["10.1080/07391102.2020.1777901", "PMC7309306", "32543978"]}, {"Citation": "Saakre M., Mathew D., Ravisankar V. Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2. Beni-Suef Univ. J. Basic Appl. Sci. 2021;10:21. doi: 10.1186/s43088-021-00107-w.", "ArticleIdList": ["10.1186/s43088-021-00107-w", "PMC7989718", "33782651"]}, {"Citation": "Elgohary S., Elkhodiry A.A., Amin N.S., Stein U., El Tayebi H.M. Thymoquinone: A tie-breaker in SARS-CoV2-infected cancer patients? Cells. 2021;10:302. doi: 10.3390/cells10020302.", "ArticleIdList": ["10.3390/cells10020302", "PMC7912962", "33540625"]}, {"Citation": "van den Berg D.F., Te Velde A.A. Severe COVID-19: NLRP3 inflammasome dysregulated. Front. Immunol. 2020;11:1580. doi: 10.3389/fimmu.2020.01580.", "ArticleIdList": ["10.3389/fimmu.2020.01580", "PMC7332883", "32670297"]}, {"Citation": "Costela-Ruiz V.J., Illescas-Montes R., Puerta-Puerta J.M., Ruiz C., Melguizo-Rodr\u00edguez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62\u201375. doi: 10.1016/j.cytogfr.2020.06.001.", "ArticleIdList": ["10.1016/j.cytogfr.2020.06.001", "PMC7265853", "32513566"]}, {"Citation": "Anil S.M., Shalev N., Vinayaka A.C., Nadarajan S., Namdar D., Belausov E., Shoval I., Mani K.A., Mechrez G., Koltai H. Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages. Sci. Rep. 2021;11:1\u201314. doi: 10.1038/s41598-021-81049-2.", "ArticleIdList": ["10.1038/s41598-021-81049-2", "PMC7809280", "33446817"]}, {"Citation": "Meeran M.N., Arunachalam S., Javed H., Sharma C., Hashiesh H.M., Goyal S.N., Jha N.K., Ojha S. Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19? Heliyon. 2020;7:e05703. doi: 10.1016/j.heliyon.2020.e05703.", "ArticleIdList": ["10.1016/j.heliyon.2020.e05703", "PMC7810623", "33490659"]}, {"Citation": "Liskova A., Samec M., Koklesova L., Samuel S.M., Zhai K., Al-Ishaq R.K., Abotaleb M., Nosal V., Kajo K., Ashrafizadeh M. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed. Pharmacother. 2021;138:111430. doi: 10.1016/j.biopha.2021.111430.", "ArticleIdList": ["10.1016/j.biopha.2021.111430", "PMC7906511", "33662680"]}, {"Citation": "Balkrishna A., Solleti S.K., Verma S., Varshney A. Application of humanized zebrafish model in the suppression of SARS-CoV-2 spike protein induced pathology by tri-herbal medicine coronil via cytokine modulation. Molecules. 2020;25:5091. doi: 10.3390/molecules25215091.", "ArticleIdList": ["10.3390/molecules25215091", "PMC7662214", "33147850"]}, {"Citation": "Lu X., Yujing S., Jie S., Friedemann T., Zhenggang T., Lu Y., Yun L., Lv Y., Ronghua Z., Zihan G. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19: Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study. Phytomedicine. 2021;85:153390.", "ArticleIdList": ["PMC7581328", "33158717"]}, {"Citation": "Khan T., Khan M.A., Ullah N., Nadhman A.J.B., Biotechnology A. Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites. Biocatal. Agric. Biotechnol. 2020;31:101890. doi: 10.1016/j.bcab.2020.101890.", "ArticleIdList": ["10.1016/j.bcab.2020.101890", "PMC7831775", "33520034"]}, {"Citation": "Fakhri S., Nouri Z., Moradi S.Z., Farzaei M.H. Astaxanthin, COVID-19 and immune response: Focus on oxidative stress, apoptosis and autophagy. Phytother. Res. 2020;34:2790\u20132792. doi: 10.1002/ptr.6797.", "ArticleIdList": ["10.1002/ptr.6797", "PMC7436866", "32754955"]}, {"Citation": "Zhang Z., Zhang X., Bi K., He Y., Yan W., Yang C.S., Zhang J. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci. Technol. 2021;114:11\u201324. doi: 10.1016/j.tifs.2021.05.023.", "ArticleIdList": ["10.1016/j.tifs.2021.05.023", "PMC8146271", "34054222"]}, {"Citation": "Du A., Zheng R., Disoma C., Li S., Chen Z., Li S., Liu P., Zhou Y., Shen Y., Liu S. Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2. Int. J. Biol. Macromol. 2021;176:1\u201312. doi: 10.1016/j.ijbiomac.2021.02.012.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.02.012", "PMC7859723", "33548314"]}, {"Citation": "Jang K.J., Choi S.H., Yu G.J., Hong S.H., Chung Y.H., Kim C.H., Yoon H.M., Kim G.Y., Kim B.W., Choi Y.H. Anti-inflammatory potential of total saponins derived from the roots of Panax ginseng in lipopolysaccharide-activated RAW 264.7 macrophages. Exp. Ther. Med. 2016;11:1109\u20131115. doi: 10.3892/etm.2015.2965.", "ArticleIdList": ["10.3892/etm.2015.2965", "PMC4774435", "26998045"]}, {"Citation": "Derouiche S. Current Review on Herbal Pharmaceutical improve immune responses against COVID-19 infection. Res. J. Pharm. Dos. Technol. 2020;12:181\u2013184. doi: 10.5958/0975-4377.2020.00031.2.", "ArticleIdList": ["10.5958/0975-4377.2020.00031.2"]}, {"Citation": "Chowdhury P., Barooah A.K. Tea bioactive modulate innate immunity: In perception to COVID-19 pandemic. Front. Immunol. 2020;11:590716. doi: 10.3389/fimmu.2020.590716.", "ArticleIdList": ["10.3389/fimmu.2020.590716", "PMC7655931", "33193427"]}, {"Citation": "Rishi P., Thakur K., Vij S., Rishi L., Singh A., Kaur I.P., Patel S.K., Lee J.-K., Kalia V.C. Diet, gut microbiota and COVID-19. Indian J. Microbiol. 2020;60:420\u2013429. doi: 10.1007/s12088-020-00908-0.", "ArticleIdList": ["10.1007/s12088-020-00908-0", "PMC7521193", "33012868"]}, {"Citation": "Donma M.M., Donma O. The effects of allium sativum on immunity within the scope of COVID-19 infection. Med. Hypotheses. 2020;144:109934. doi: 10.1016/j.mehy.2020.109934.", "ArticleIdList": ["10.1016/j.mehy.2020.109934", "PMC7265825", "32512493"]}, {"Citation": "Brendler T., Al-Harrasi A., Bauer R., Gafner S., Hardy M.L., Heinrich M., Hosseinzadeh H., Izzo A.A., Michaelis M., Nassiri-Asl M. Botanical drugs and supplements affecting the immune response in the time of COVID-19: Implications for research and clinical practice. Phytother. Res. 2021;35:3013\u20133031. doi: 10.1002/ptr.7008.", "ArticleIdList": ["10.1002/ptr.7008", "33373071"]}, {"Citation": "Wang M., Chen D.-Q., Wang M.-C., Chen H., Chen L., Liu D., Zhao H., Zhao Y.-Y. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-\u03b2/Smad signaling pathway. Phytomedicine. 2017;36:243\u2013253. doi: 10.1016/j.phymed.2017.10.008.", "ArticleIdList": ["10.1016/j.phymed.2017.10.008", "29157821"]}, {"Citation": "Wang M., Chen D.-Q., Chen L., Liu D., Zhao H., Zhang Z.-H., Vaziri N.D., Guo Y., Zhao Y.-Y., Cao G. Novel RAS inhibitors poricoic acid ZG and poricoic acid ZH attenuate renal fibrosis via a Wnt/\u03b2-catenin pathway and targeted phosphorylation of smad3 signaling. J. Agric. Food. Chem. 2018;66:1828\u20131842. doi: 10.1021/acs.jafc.8b00099.", "ArticleIdList": ["10.1021/acs.jafc.8b00099", "29383936"]}, {"Citation": "Chen H., Yang T., Wang M.-C., Chen D.-Q., Yang Y., Zhao Y.-Y. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-\u03b2-mediated Smad3 phosphorylation. Phytomedicine. 2018;42:207\u2013218. doi: 10.1016/j.phymed.2018.03.034.", "ArticleIdList": ["10.1016/j.phymed.2018.03.034", "29655688"]}, {"Citation": "Jiang C., Shao Q., Jin B., Gong R., Zhang M., Xu B. Tanshinone IIA attenuates renal fibrosis after acute kidney injury in a mouse model through inhibition of fibrocytes recruitment. Biomed. Res. Int. 2015;2015:867140. doi: 10.1155/2015/867140.", "ArticleIdList": ["10.1155/2015/867140", "PMC4739267", "26885500"]}, {"Citation": "Cheng H., Bo Y., Shen W., Tan J., Jia Z., Xu C., Li F. Leonurine ameliorates kidney fibrosis via suppressing TGF-\u03b2 and NF-\u03baB signaling pathway in UUO mice. Int. Immunopharmacol. 2015;25:406\u2013415. doi: 10.1016/j.intimp.2015.02.023.", "ArticleIdList": ["10.1016/j.intimp.2015.02.023", "25727888"]}, {"Citation": "Ma Z., Tang Y., Zhong L., Yu K., He L. Anti-fibrosis and relative mechanism of salvianolic acid A on rat model with renal fibrosis. Int. J. Clin. Exp. Med. 2016;9:12713\u201312720."}, {"Citation": "Yuan X.P., Liu L.S., Fu Q., Wang C.X. Effects of Ligustrazine on Ureteral Obstruction-induced Renal Tubulointerstitial Fibrosis. Phytother. Res. 2012;26:697\u2013703. doi: 10.1002/ptr.3630.", "ArticleIdList": ["10.1002/ptr.3630", "22006851"]}, {"Citation": "Zhang B.-Z., Guo X.-T., Chen J.-W., Zhao Y., Cong X., Jiang Z.-L., Cao R.-F., Cui K., Gao S.-S., Tian W.-R. Saikosaponin-D attenuates heat stress-induced oxidative damage in LLC-PK1 cells by increasing the expression of anti-oxidant enzymes and HSP72. Am. J. Chin. Med. 2014;42:1261\u20131277. doi: 10.1142/S0192415X14500797.", "ArticleIdList": ["10.1142/S0192415X14500797", "25169909"]}, {"Citation": "Yuan X.P., He X.S., Wang C.X., Liu L.S., Fu Q. Triptolide attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrology. 2011;16:200\u2013210. doi: 10.1111/j.1440-1797.2010.01359.x.", "ArticleIdList": ["10.1111/j.1440-1797.2010.01359.x", "21272133"]}, {"Citation": "Shokeir A.A., Barakat N., Hussein A.M., Awadalla A., Harraz A., Khater S., Hemmaid K., Kamal A.I. Activation of Nrf2 by ischemic preconditioning and sulforaphane in renal ischemia/reperfusion injury: A comparative experimental study. Physiol. Res. 2015;64:313. doi: 10.33549/physiolres.932834.", "ArticleIdList": ["10.33549/physiolres.932834", "25536319"]}, {"Citation": "Paix\u00e3o J., Dinis T.C., Almeida L.M. Malvidin-3-glucoside protects endothelial cells up-regulating endothelial NO synthase and inhibiting peroxynitrite-induced NF-kB activation. Chem. Biol. Interact. 2012;199:192\u2013200. doi: 10.1016/j.cbi.2012.08.013.", "ArticleIdList": ["10.1016/j.cbi.2012.08.013", "22959858"]}, {"Citation": "Jang Y.J., Park B., Lee H.-W., Park H.J., Koo H.J., Kim B.O., Sohn E.-H., Um S.H., Pyo S. Sinigrin attenuates the progression of atherosclerosis in ApoE\u2212/\u2212 mice fed a high-cholesterol diet potentially by inhibiting VCAM-1 expression. Chem. Biol. Interact. 2017;272:28\u201336. doi: 10.1016/j.cbi.2017.05.006.", "ArticleIdList": ["10.1016/j.cbi.2017.05.006", "28483571"]}, {"Citation": "Skemiene K., Rakauskaite G., Trumbeckaite S., Liobikas J., Brown G.C., Borutaite V. Anthocyanins block ischemia-induced apoptosis in the perfused heart and support mitochondrial respiration potentially by reducing cytosolic cytochrome c. Int. J. Biochem. Cell Biol. 2013;45:23\u201329. doi: 10.1016/j.biocel.2012.07.022.", "ArticleIdList": ["10.1016/j.biocel.2012.07.022", "22842532"]}, {"Citation": "Nagi M.N., Al-Shabanah O.A., Hafez M.M., Sayed-Ahmed M.M. Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats. J. Biochem. Mol. Toxicol. 2011;25:135\u2013142. doi: 10.1002/jbt.20369.", "ArticleIdList": ["10.1002/jbt.20369", "20957680"]}, {"Citation": "Zheng X., Wang S., Zou X., Jing Y., Yang R., Li S., Wang F. Ginsenoside Rb1 improves cardiac function and remodeling in heart failure. Exp. Anim. 2017;66:217\u2013228. doi: 10.1538/expanim.16-0121.", "ArticleIdList": ["10.1538/expanim.16-0121", "PMC5543242", "28367863"]}, {"Citation": "Paiva L., Lima E., Neto A.I., Baptista J. Angiotensin I-converting enzyme (ACE) inhibitory activity of Fucus spiralis macroalgae and influence of the extracts storage temperature\u2014A short report. J. Pharm. Biomed. Anal. 2016;131:503\u2013507. doi: 10.1016/j.jpba.2016.08.029.", "ArticleIdList": ["10.1016/j.jpba.2016.08.029", "27595387"]}, {"Citation": "Agrawal K., Melliou E., Li X., Pedersen T.L., Wang S.C., Magiatis P., Newman J.W., Holt R.R. Oleocanthal-rich extra virgin olive oil demonstrates acute anti-platelet effects in healthy men in a randomized trial. J. Funct. Foods. 2017;36:84\u201393. doi: 10.1016/j.jff.2017.06.046.", "ArticleIdList": ["10.1016/j.jff.2017.06.046", "PMC5995573", "29904393"]}, {"Citation": "Zhang T., Yang S., Du J. Protective effects of berberine on isoproterenol-induced acute myocardial ischemia in rats through regulating HMGB1-TLR4 axis. Evid. Based Complement. Altern. Med. 2014;2014:849783. doi: 10.1155/2014/849783.", "ArticleIdList": ["10.1155/2014/849783", "PMC4247925", "25477998"]}, {"Citation": "Yang L., Zhang Y., Zhu M., Zhang Q., Wang X., Wang Y., Zhang J., Li J., Yang L., Liu J. Resveratrol attenuates myocardial ischemia/reperfusion injury through up-regulation of vascular endothelial growth factor B. Free Radic. Biol. Med. 2016;101:1\u20139. doi: 10.1016/j.freeradbiomed.2016.09.016.", "ArticleIdList": ["10.1016/j.freeradbiomed.2016.09.016", "27667182"]}, {"Citation": "Hua S., Ma M., Fei X., Zhang Y., Gong F., Fang M. Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis. Int. Immunopharmacol. 2019;68:145\u2013155. doi: 10.1016/j.intimp.2019.01.002.", "ArticleIdList": ["10.1016/j.intimp.2019.01.002", "30634142"]}, {"Citation": "Zhang H.-L., Dai L.-H., Wu Y.-H., Yu X.-P., Zhang Y.-Y., Guan R.-F., Liu T., Zhao J.J.B., Bulletin P. Evaluation of hepatocyteprotective and anti-hepatitis B virus properties of Cichoric acid from Cichorium intybus leaves in cell culture. Biol. Pharm. Bull. 2014;37:1214\u20131220. doi: 10.1248/bpb.b14-00137.", "ArticleIdList": ["10.1248/bpb.b14-00137", "24759764"]}, {"Citation": "Bruck R., Ashkenazi M., Weiss S., Goldiner I., Shapiro H., Aeed H., Genina O., Helpern Z., Pines M. Prevention of liver cirrhosis in rats by curcumin. Liver Int. 2007;27:373\u2013383. doi: 10.1111/j.1478-3231.2007.01453.x.", "ArticleIdList": ["10.1111/j.1478-3231.2007.01453.x", "17355460"]}, {"Citation": "Kang M.-C., Kang S.-M., Ahn G., Kim K.-N., Kang N., Samarakoon K.W., Oh M.-C., Lee J.-S., Jeon Y.-J. Protective effect of a marine polyphenol, dieckol against carbon tetrachloride-induced acute liver damage in mouse. Environ. Toxicol. Pharmacol. 2013;35:517\u2013523. doi: 10.1016/j.etap.2013.02.013.", "ArticleIdList": ["10.1016/j.etap.2013.02.013", "23528870"]}, {"Citation": "Ma J.Q., Ding J., Zhao H., Liu C.M. Puerarin attenuates carbon tetrachloride-induced liver oxidative stress and hyperlipidaemia in mouse by JNK/c-Jun/CYP7A1 pathway. Basic Clin. Pharmacol. Toxicol. 2014;115:389\u2013395. doi: 10.1111/bcpt.12245.", "ArticleIdList": ["10.1111/bcpt.12245", "24698568"]}, {"Citation": "Calland N., Sahuc M.-E., Belouzard S., P\u00e8ne V., Bonnafous P., Mesalam A.A., Deloison G., Descamps V., Sahpaz S., Wychowski C. Polyphenols inhibit hepatitis C virus entry by a new mechanism of action. J. Virol. 2015;89:10053\u201310063. doi: 10.1128/JVI.01473-15.", "ArticleIdList": ["10.1128/JVI.01473-15", "PMC4577911", "26202241"]}, {"Citation": "Rasool M.K., Sabina E.P., Ramya S.R., Preety P., Patel S., Mandal N., Mishra P.P., Samuel J. Pharmacology, Hepatoprotective and antioxidant effects of gallic acid in paracetamol-induced liver damage in mice. J. Pharm. Ther. 2010;62:638\u2013643.", "ArticleIdList": ["20609067"]}, {"Citation": "Sun H., Che Q.-M., Zhao X., Pu X.-P. Antifibrotic effects of chronic baicalein administration in a CCl4 liver fibrosis model in rats. Eur. J. Pharmacol. 2010;631:53\u201360. doi: 10.1016/j.ejphar.2010.01.002.", "ArticleIdList": ["10.1016/j.ejphar.2010.01.002", "20079350"]}, {"Citation": "Zhang Z.-F., Zhang Y.-Q., Fan S.-H., Zhuang J., Zheng Y.-L., Lu J., Wu D.-M., Shan Q., Hu B. Troxerutin protects against 2, 2\u2032, 4, 4\u2032-tetrabromodiphenyl ether (BDE-47)-induced liver inflammation by attenuating oxidative stress-mediated NAD+-depletion. J. Hazard. Mater. 2015;283:98\u2013109. doi: 10.1016/j.jhazmat.2014.09.012.", "ArticleIdList": ["10.1016/j.jhazmat.2014.09.012", "25262482"]}, {"Citation": "Ren J., Fan C., Chen N., Huang J., Yang Q. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem. Res. 2011;36:2352\u20132362. doi: 10.1007/s11064-011-0561-8.", "ArticleIdList": ["10.1007/s11064-011-0561-8", "21850487"]}, {"Citation": "Hussein R.M., Mohamed W.R., Omar H.A. A neuroprotective role of kaempferol against chlorpyrifos-induced oxidative stress and memory deficits in rats via GSK3\u03b2-Nrf2 signaling pathway. Pestic. Biochem. Physiol. 2018;152:29\u201337. doi: 10.1016/j.pestbp.2018.08.008.", "ArticleIdList": ["10.1016/j.pestbp.2018.08.008", "30497708"]}, {"Citation": "Xiao G., Lyu M., Wang Y., He S., Liu X., Ni J., Li L., Fan G., Han J., Gao X. Ginkgo Flavonol Glycosides or Ginkgolides Tend to Differentially Protect Myocardial or Cerebral Ischemia\u2013Reperfusion Injury via Regulation of TWEAK-Fn14 Signaling in Heart and Brain. Front. Pharmacol. 2019;10:735. doi: 10.3389/fphar.2019.00735.", "ArticleIdList": ["10.3389/fphar.2019.00735", "PMC6624656", "31333457"]}, {"Citation": "Song Z., Han S., Pan X., Gong Y., Wang M. Pharmacology, Pterostilbene mediates neuroprotection against oxidative toxicity via oestrogen receptor \u03b1 signalling pathways. J. Pharm. Pharmacol. 2015;67:720\u2013730. doi: 10.1111/jphp.12360.", "ArticleIdList": ["10.1111/jphp.12360", "25644078"]}, {"Citation": "Chen P., Lin X., Yang C.-H., Tang X., Chang Y.-W., Zheng W., Luo L., Xu C., Chen Y.-H. Study on chemical profile and neuroprotective activity of Myrica rubra leaf extract. Molecules. 2017;22:1226. doi: 10.3390/molecules22071226.", "ArticleIdList": ["10.3390/molecules22071226", "PMC6152229", "28737731"]}, {"Citation": "Pegorini S., Braida D., Verzoni C., Guerini-Rocco C., Consalez G.G., Croci L., Sala M. Capsaicin exhibits neuroprotective effects in a model of transient global cerebral ischemia in Mongolian gerbils. Br. J. Pharmacol. 2005;144:727\u2013735. doi: 10.1038/sj.bjp.0706115.", "ArticleIdList": ["10.1038/sj.bjp.0706115", "PMC1576053", "15678080"]}, {"Citation": "Koh S.S., Ooi S.C.-Y., Lui N.M.-Y., Qiong C., Ho L.T.-Y., Cheah I.K.-M., Halliwell B., Herr D.R., Ong W.-Y. Effect of ergothioneine on 7-ketocholesterol-induced endothelial injury. Neuromol. Med. 2021;23:184\u2013198. doi: 10.1007/s12017-020-08620-4.", "ArticleIdList": ["10.1007/s12017-020-08620-4", "PMC7567423", "33067719"]}, {"Citation": "Wang J., Li P., Qin T., Sun D., Zhao X., Zhang B. Protective effect of epigallocatechin-3-gallate against neuroinflammation and anxiety-like behavior in a rat model of myocardial infarction. Brain Behav. 2020;10:e01633. doi: 10.1002/brb3.1633.", "ArticleIdList": ["10.1002/brb3.1633", "PMC7303397", "32304289"]}, {"Citation": "Mammana S., Cavalli E., Gugliandolo A., Silvestro S., Pollastro F., Bramanti P., Mazzon E. Could the combination of two non-psychotropic cannabinoids counteract neuroinflammation? Effectiveness of cannabidiol associated with cannabigerol. Medicina. 2019;55:747. doi: 10.3390/medicina55110747.", "ArticleIdList": ["10.3390/medicina55110747", "PMC6915685", "31752240"]}, {"Citation": "Amann K., Boor P., Wiech T., Singh J., Vonbrunn E., Kn\u00f6ll A., Hermann M., B\u00fcttner-Herold M., Daniel C., Hartmann A. COVID-19 effects on the kidney. Pathology. 2021;42:183\u2013187.", "ArticleIdList": ["PMC7849614", "33527157"]}, {"Citation": "Chan L., Chaudhary K., Saha A., Chauhan K., Vaid A., Zhao S., Paranjpe I., Somani S., Richter F., Miotto R. AKI in hospitalized patients with COVID-19. J. Am. Soc. Nephrol. 2021;32:151\u2013160. doi: 10.1681/ASN.2020050615.", "ArticleIdList": ["10.1681/ASN.2020050615", "PMC7894657", "32883700"]}, {"Citation": "Benedetti C., Waldman M., Zaza G., Riella L.V., Cravedi P. COVID-19 and the kidneys: An update. Front. Med. (Lausanne) 2020;7:423. doi: 10.3389/fmed.2020.00423.", "ArticleIdList": ["10.3389/fmed.2020.00423", "PMC7385132", "32793615"]}, {"Citation": "Sfera A., Osorio C., Jafri N., Diaz E.L., Campo Maldonado J.E. Intoxication with endogenous angiotensin II: A COVID-19 hypothesis. Front. Immunol. 2020;11:1472. doi: 10.3389/fimmu.2020.01472.", "ArticleIdList": ["10.3389/fimmu.2020.01472", "PMC7325923", "32655579"]}, {"Citation": "de Queiroz T.M., Lakkappa N., Lazartigues E. ADAM17-mediated shedding of inflammatory cytokines in hypertension. Front. Pharmacol. 2020;11:1154. doi: 10.3389/fphar.2020.01154.", "ArticleIdList": ["10.3389/fphar.2020.01154", "PMC7403492", "32848763"]}, {"Citation": "Larsen C.P., Bourne T.D., Wilson J.D., Saqqa O., Sharshir M.A. Collapsing glomerulopathy in a patient with COVID-19. Kidney Int. Rep. 2020;5:935\u2013939. doi: 10.1016/j.ekir.2020.04.002.", "ArticleIdList": ["10.1016/j.ekir.2020.04.002", "PMC7142700", "32292867"]}, {"Citation": "Kissling S., Rotman S., Gerber C., Halfon M., Lamoth F., Comte D., Lhopitallier L., Sadallah S., Fakhouri F. Collapsing glomerulopathy in a COVID-19 patient. Kidney Int. 2020;98:228\u2013231. doi: 10.1016/j.kint.2020.04.006.", "ArticleIdList": ["10.1016/j.kint.2020.04.006", "PMC7156952", "32471639"]}, {"Citation": "Su H., Yang M., Wan C., Yi L.-X., Tang F., Zhu H.-Y., Yi F., Yang H.-C., Fogo A.B., Nie X. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98:219\u2013227. doi: 10.1016/j.kint.2020.04.003.", "ArticleIdList": ["10.1016/j.kint.2020.04.003", "PMC7194105", "32327202"]}, {"Citation": "Li Z., Wu M., Yao J., Guo J., Liao X., Song S., Li J., Duan G., Zhou Y., Wu X. Caution on kidney dysfunctions of COVID-19 patients. MedRxiv. 2020 doi: 10.2139/ssrn.3559601.", "ArticleIdList": ["10.2139/ssrn.3559601"]}, {"Citation": "Chen J., Wang W., Tang Y., Huang X.-R., Yu X., Lan H.-Y. Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury. Int. J. Biol. Sci. 2021;17:1497. doi: 10.7150/ijbs.58791.", "ArticleIdList": ["10.7150/ijbs.58791", "PMC8071761", "33907513"]}, {"Citation": "Ferreira-Gomes M., Kruglov A., Durek P., Heinrich F., Tizian C., Heinz G.A., Pascual-Reguant A., Du W., Mothes R., Fan C. SARS-CoV-2 in severe COVID-19 induces a TGF-\u03b2-dominated chronic immune response that does not target itself. Nat. Commun. 2021;12:1\u201314. doi: 10.1038/s41467-021-22210-3.", "ArticleIdList": ["10.1038/s41467-021-22210-3", "PMC8010106", "33785765"]}, {"Citation": "Gu Y.-Y., Zhang M., Cen H., Wu Y.-F., Lu Z., Lu F., Liu X.-S., Lan H.-Y. Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study. PLoS ONE. 2021;16:e0245209. doi: 10.1371/journal.pone.0245209.", "ArticleIdList": ["10.1371/journal.pone.0245209", "PMC7808608", "33444408"]}, {"Citation": "Tan R.Z., Wang C., Deng C., Zhong X., Yan Y., Luo Y., Lan H.Y., He T., Wang L. Quercetin protects against cisplatin-induced acute kidney injury by inhibiting Mincle/Syk/NF-\u03baB signaling maintained macrophage inflammation. Phytother. Res. 2020;34:139\u2013152. doi: 10.1002/ptr.6507.", "ArticleIdList": ["10.1002/ptr.6507", "31497913"]}, {"Citation": "Lippi G., Plebani M.J.C.C., Medicine L. Laboratory abnormalities in patients with COVID-2019 infection. Clin. Chem. Lab. Med. 2020;58:1131\u20131134. doi: 10.1515/cclm-2020-0198.", "ArticleIdList": ["10.1515/cclm-2020-0198", "32119647"]}, {"Citation": "Arentz M., Yim E., Klaff L., Lokhandwala S., Riedo F.X., Chong M., Lee M. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020;323:1612\u20131614. doi: 10.1001/jama.2020.4326.", "ArticleIdList": ["10.1001/jama.2020.4326", "PMC7082763", "32191259"]}, {"Citation": "Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiol. 2020;5:831\u2013840. doi: 10.1001/jamacardio.2020.1286.", "ArticleIdList": ["10.1001/jamacardio.2020.1286", "32219363"]}, {"Citation": "Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab. Syndr. 2020;14:247\u2013250. doi: 10.1016/j.dsx.2020.03.013.", "ArticleIdList": ["10.1016/j.dsx.2020.03.013", "PMC7102662", "32247212"]}, {"Citation": "Liu Q., Tian J., Xu Y., Li C., Meng X., Fu F. Protective effect of RA on myocardial infarction-induced cardiac fibrosis via AT1R/p38 MAPK pathway signaling and modulation of the ACE2/ACE ratio. J. Agric. Food Chem. 2016;64:6716\u20136722. doi: 10.1021/acs.jafc.6b03001.", "ArticleIdList": ["10.1021/acs.jafc.6b03001", "27538767"]}, {"Citation": "Wang Z., Pang W., He C., Li Y., Jiang Y., Guo C. Blueberry anthocyanin-enriched extracts attenuate fine particulate matter (PM2. 5)-induced cardiovascular dysfunction. J. Agric. Food Chem. 2017;65:87\u201394. doi: 10.1021/acs.jafc.6b04603.", "ArticleIdList": ["10.1021/acs.jafc.6b04603", "27996266"]}, {"Citation": "Escudero-L\u00f3pez B., Bern\u00e1 G., Ortega \u00c1., Herrero-Mart\u00edn G., Cerrillo I., Mart\u00edn F., Fern\u00e1ndez-Pach\u00f3n M.-S. Consumption of orange fermented beverage reduces cardiovascular risk factors in healthy mice. Food Chem. Toxicol. 2015;78:78\u201385. doi: 10.1016/j.fct.2015.02.006.", "ArticleIdList": ["10.1016/j.fct.2015.02.006", "25666657"]}, {"Citation": "Sa-Ngiamsuntorn K., Suksatu A., Pewkliang Y., Thongsri P., Kanjanasirirat P., Manopwisedjaroen S., Charoensutthivarakul S., Wongtrakoongate P., Pitiporn S., Chaopreecha J. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component Andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. J. Nat. Prod. 2021;84:1261\u20131270. doi: 10.1021/acs.jnatprod.0c01324.", "ArticleIdList": ["10.1021/acs.jnatprod.0c01324", "33844528"]}, {"Citation": "Wang B., Kovalchuk A., Li D., Rodriguez-Juarez R., Ilnytskyy Y., Kovalchuk I., Kovalchuk O. In search of preventive strategies: Novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues. Aging. 2020;12:22425\u201322444.", "ArticleIdList": ["PMC7746344", "33221759"]}, {"Citation": "Orlando G., Chiavaroli A., Adorisio S., Delfino D.V., Brunetti L., Recinella L., Leone S., Zengin G., Acquaviva A., Angelini P. Unravelling the Phytochemical Composition and the Pharmacological Properties of an Optimized Extract from the Fruit from Prunus mahaleb L.: From Traditional Liqueur Market to the Pharmacy Shelf. Molecules. 2021;26:4422. doi: 10.3390/molecules26154422.", "ArticleIdList": ["10.3390/molecules26154422", "PMC8347645", "34361576"]}, {"Citation": "Gandhi S., Srivastava A.K., Ray U., Tripathi P.P. Is the collapse of the respiratory center in the brain responsible for respiratory breakdown in COVID-19 patients? ACS Chem. Neurosci. 2020;11:1379\u20131381. doi: 10.1021/acschemneuro.0c00217.", "ArticleIdList": ["10.1021/acschemneuro.0c00217", "32348111"]}, {"Citation": "Al-Ramadan A., Rabab\u2019h O., Shah J., Gharaibeh A. Acute and post-acute neurological complications of COVID-19. Neurol. Int. 2021;13:102\u2013119. doi: 10.3390/neurolint13010010.", "ArticleIdList": ["10.3390/neurolint13010010", "PMC8006051", "33803475"]}, {"Citation": "Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507\u2013513. doi: 10.1016/S0140-6736(20)30211-7.", "ArticleIdList": ["10.1016/S0140-6736(20)30211-7", "PMC7135076", "32007143"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683\u2013690. doi: 10.1001/jamaneurol.2020.1127.", "ArticleIdList": ["10.1001/jamaneurol.2020.1127", "PMC7149362", "32275288"]}, {"Citation": "Li Y., Li M., Wang M., Zhou Y., Chang J., Xian Y., Wang D., Mao L., Jin H., Hu B. Acute cerebrovascular disease following COVID-19: A single center, retrospective, observational study. Stroke Vasc. Neurol. 2020;5:279\u2013284. doi: 10.1136/svn-2020-000431.", "ArticleIdList": ["10.1136/svn-2020-000431", "PMC7371480", "32616524"]}, {"Citation": "Scullen T., Keen J., Mathkour M., Dumont A.S., Kahn L. Coronavirus 2019 (COVID-19)\u2013associated encephalopathies and cerebrovascular disease: The New Orleans experience. World Neurosurg. 2020;141:e437\u2013e446. doi: 10.1016/j.wneu.2020.05.192.", "ArticleIdList": ["10.1016/j.wneu.2020.05.192", "PMC7255727", "32474092"]}, {"Citation": "Pedersen S.F., Ho Y.-C. SARS-CoV-2: A storm is raging. J. Clin. Investig. 2020;130:2202\u20132205. doi: 10.1172/JCI137647.", "ArticleIdList": ["10.1172/JCI137647", "PMC7190904", "32217834"]}, {"Citation": "Guti\u00e9rrez-Ortiz C., M\u00e9ndez-Guerrero A., Rodrigo-Rey S., San Pedro-Murillo E., Bermejo-Guerrero L., Gordo-Ma\u00f1as R., de Arag\u00f3n-G\u00f3mez F., Benito-Le\u00f3n J. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95:e601\u2013e605. doi: 10.1212/WNL.0000000000009619.", "ArticleIdList": ["10.1212/WNL.0000000000009619", "32303650"]}, {"Citation": "Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lan Psychy. 2021;8:416\u2013427. doi: 10.1016/S2215-0366(21)00084-5.", "ArticleIdList": ["10.1016/S2215-0366(21)00084-5", "PMC8023694", "33836148"]}, {"Citation": "Rajkumar R.P. Ayurveda and COVID-19: Where psychoneuroimmunology and the meaning response meet. Brain. Behav. Immun. 2020;87:8\u20139. doi: 10.1016/j.bbi.2020.04.056.", "ArticleIdList": ["10.1016/j.bbi.2020.04.056", "PMC7175849", "32334064"]}, {"Citation": "Kempuraj D., Thangavel R., Kempuraj D.D., Ahmed M.E., Selvakumar G.P., Raikwar S.P., Zaheer S.A., Iyer S.S., Govindarajan R., Chandrasekaran P.N. Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. Biofactors. 2021;47:190\u2013197. doi: 10.1002/biof.1687.", "ArticleIdList": ["10.1002/biof.1687", "33098588"]}, {"Citation": "Theoharides T., Conti P. COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome. J. Biol. Regul. Homeost. Agents. 2020;34:1633\u20131636.", "ArticleIdList": ["33023287"]}, {"Citation": "Martinez M.A., Franco S. Impact of COVID-19 in liver disease progression. Hepatol. Commun. 2021;5:1138\u20131150. doi: 10.1002/hep4.1745.", "ArticleIdList": ["10.1002/hep4.1745", "PMC8239862", "34533001"]}, {"Citation": "Bertolini A., van de Peppel I.P., Bodewes F., Moshage H., Fantin A., Farinati F., Fiorotto R., Jonker J.W., Strazzabosco M., Verkade H. Abnormal liver function tests in patients with COVID-19: Relevance and potential pathogenesis. Hepatology. 2020;72:1864\u20131872. doi: 10.1002/hep.31480.", "ArticleIdList": ["10.1002/hep.31480", "PMC7404414", "32702162"]}, {"Citation": "Phipps M.M., Barraza L.H., LaSota E.D., Sobieszczyk M.E., Pereira M.R., Zheng E.X., Fox A.N., Zucker J., Verna E.C. Acute liver injury in COVID-19: Prevalence and association with clinical outcomes in a large US cohort. Hepatology. 2020;72:807\u2013817. doi: 10.1002/hep.31404.", "ArticleIdList": ["10.1002/hep.31404", "PMC7300739", "32473607"]}, {"Citation": "Zhang C., Shi L., Wang F.-S. Liver injury in COVID-19: Management and challenges. Lancet Gastroenterol. Hepatol. 2020;5:428\u2013430. doi: 10.1016/S2468-1253(20)30057-1.", "ArticleIdList": ["10.1016/S2468-1253(20)30057-1", "PMC7129165", "32145190"]}, {"Citation": "Zhao B., Ni C., Gao R., Wang Y., Yang L., Wei J., Lv T., Liang J., Zhang Q., Xu W., et al. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell. 2020;11:771\u2013775. doi: 10.1007/s13238-020-00718-6.", "ArticleIdList": ["10.1007/s13238-020-00718-6", "PMC7164704", "32303993"]}, {"Citation": "Wang Y., Liu S., Liu H., Li W., Lin F., Jiang L., Li X., Xu P., Zhang L., Zhao L. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J. Hepatol. 2020;73:807\u2013816. doi: 10.1016/j.jhep.2020.05.002.", "ArticleIdList": ["10.1016/j.jhep.2020.05.002", "PMC7211738", "32437830"]}, {"Citation": "Goldman J.D., Lye D.C., Hui D.S., Marks K.M., Bruno R., Montejano R., Spinner C.D., Galli M., Ahn M.-Y., Nahass R.G., et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N. Engl. J. Med. 2020;383:1827\u20131837. doi: 10.1056/NEJMoa2015301.", "ArticleIdList": ["10.1056/NEJMoa2015301", "PMC7377062", "32459919"]}, {"Citation": "Hernandez A.V., Roman Y.M., Pasupuleti V., Barboza J.J., White C.M. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: A living systematic review. Ann. Intern. Med. 2020;173:287\u2013296. doi: 10.7326/M20-2496.", "ArticleIdList": ["10.7326/M20-2496", "32459529"]}, {"Citation": "Hodgman M.J., Garrard A.R. A review of acetaminophen poisoning. Crit. Care Clin. 2012;28:499\u2013516. doi: 10.1016/j.ccc.2012.07.006.", "ArticleIdList": ["10.1016/j.ccc.2012.07.006", "22998987"]}, {"Citation": "Li H., Hu Y., Tang H., Li S., Ding H., Zhai S., Zhao R. The Potential of Glycyrrhizinate in the Management of COVID-19: A Systematic Review of the Efficacy and Safety of Glycyrrhizin Preparations in the Treatment of SARS and MERS. Am. J. Chin. Med. 2020;48:1539\u20131552. doi: 10.1142/S0192415X20500767.", "ArticleIdList": ["10.1142/S0192415X20500767", "33202150"]}, {"Citation": "Liao F.L., Peng D.H., Chen W., Hu H.N., Tang P., Liu Y.Y., Luo Y., Yao T. Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes. J. Med. Virol. 2021;93:2365\u20132373. doi: 10.1002/jmv.26729.", "ArticleIdList": ["10.1002/jmv.26729", "33314141"]}, {"Citation": "Tan R., Xiang X., Chen W., Yang Z., Hu W., Qu H., Liu J. Efficacy of diammonium glycyrrhizinate combined with vitamin C for treating hospitalized COVID-19 patients: A retrospective, observational study. QJM Int. J. Med. :2021. doi: 10.1093/qjmed/hcab184.", "ArticleIdList": ["10.1093/qjmed/hcab184", "PMC8420637", "34314507"]}, {"Citation": "Roshdy W.H., Rashed H.A., Kandeil A., Mostafa A., Moatasim Y., Kutkat O., Abo Shama N.M., Gomaa M.R., El-Sayed I.H., El Guindy N.M. EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS ONE. 2020;15:e0241739. doi: 10.1371/journal.pone.0241739.", "ArticleIdList": ["10.1371/journal.pone.0241739", "PMC7673558", "33206688"]}, {"Citation": "Storz M.A. Lifestyle Adjustments in Long-COVID Management: Potential Benefits of Plant-Based Diets. Curr. Nutr. Rep. 2021:1\u201312. doi: 10.1007/s13668-021-00369-x.", "ArticleIdList": ["10.1007/s13668-021-00369-x", "PMC8429479", "34506003"]}, {"Citation": "Girija P., Sivan N. Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report. J. Ayurveda Integr. Med. 2020 doi: 10.1016/j.jaim.2020.06.001. in press.", "ArticleIdList": ["10.1016/j.jaim.2020.06.001", "PMC7303645", "32680602"]}, {"Citation": "Huang Z., Fu F., Ye H., Gao H., Tan B., Wang R., Lin N., Qin L., Chen W. Chinese herbal Huo-Gu formula for the treatment of steroid-associated osteonecrosis of femoral head: A 14-year follow-up of convalescent SARS patients. J. Orthop. Translat. 2020;23:122\u2013131. doi: 10.1016/j.jot.2020.03.014.", "ArticleIdList": ["10.1016/j.jot.2020.03.014", "PMC7129775", "32292697"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "11"}, {"Year": "2021", "Month": "11", "Day": "2"}, {"Year": "2021", "Month": "11", "Day": "4"}, {"Year": "2021", "Month": "11", "Day": "27", "Hour": "1", "Minute": "23"}, {"Year": "2021", "Month": "11", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["34833873", "PMC8621307", "10.3390/molecules26226783", "molecules26226783"]}}], "PubmedBookArticle": []}